Open access
Open access
Powered by Google Translator Translator

Radiology - Breast

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

5 Mar, 2021 | 08:35h | UTC

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Recommendations: Pharmacovigilance Evidence Review: The effect of COVID-19 vaccines on breast screening – Drug Safety Research Unit

Related: 2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients


2 Case Series and Guidance| Lymphadenopathy in COVID-19 Vaccine Recipients

28 Feb, 2021 | 21:42h | UTC

Case series: Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients – Radiology

Related case series in women without cancer: Coronavirus Disease (COVID-19) Vaccination Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women – American Journal of Roentgenology

Related guidance 1: Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel – Radiology

Related guidance 2: Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach – American Journal of Roentgenology AND Commentary: What to do when a mammogram shows swollen lymph nodes in women just vaccinated for COVID – Massachusetts General Hospital

Commentary: COVID-19 vaccine affects imaging results, researchers warn – AuntMinnie (free registration required)


Cost-effective analysis suggests incorporating baseline breast density at 40 years to determine the frequency of screening in women at average risk for breast cancer

10 Feb, 2021 | 01:37h | UTC

Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer: A Cost-Effectiveness Analysis – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: Screening based on breast density at age 40 may reduce breast cancer mortality – ACP Internist AND Screening strategy based on baseline breast density at age 40 may be effective for reducing breast cancer mortality – American College of Physicians AND For Mammography: Baseline at 40 Makes Sense – Diagnostic Imaging


Commentary on Twitter


PET imaging reveals which breast cancer patients won’t respond to hormone therapy

10 Feb, 2021 | 01:09h | UTC

PET Imaging Reveals Which Breast Cancer Patients Won’t Respond to Hormone Therapy – Diagnostic Imaging

Original study: Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy – Nature Communications


COVID-19 vaccine-linked adenopathies could mimic breast malignancies

2 Feb, 2021 | 01:17h | UTC

COVID-19 Vaccine-Linked Adenopathies Could Mimic Breast Malignancies – Diagnostic Imaging

Original Study: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine – Clinical Imaging


Commentaries on Twitter


Consensus statement recommends individualizing surveillance mammography for older patients after treatment for early-stage breast cancer

1 Feb, 2021 | 01:33h | UTC

Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement – JAMA Oncology

Commentaries: First Mammography Guidelines Released for Older Breast Cancer Survivors – Diagnostic Imaging AND New Surveillance Mammography Screening Guidelines Issued for Breast Cancer Survivors Aged 75 and Older – The ASCO Post


Stay Updated in Your Specialty

No spam, just news.